VIM and cervical carcinoma: NKX6.1 could recruit the BAF155 coactivator to enhance the mRNA level of E-cadherin and recruit the RBBP7 (retinoblastoma binding protein 7) corepressor to repress that of vimentin in cervical cancer [20].